Achillion Pharmaceuticals, Inc.
(NASDAQ : ACHN)

( )
ACHN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ACHN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.16%70.550.9%$746.71m
AMGNAmgen Inc.
0.00%170.851.1%$707.06m
CELGCelgene Corporation
0.00%130.931.1%$645.79m
REGNRegeneron Pharmaceuticals, Inc.
0.00%502.122.7%$590.62m
BIIBBiogen Inc.
0.00%271.251.2%$491.73m
ALXNAlexion Pharmaceuticals, Inc.
-1.24%120.601.9%$445.24m
VRTXVertex Pharmaceuticals Incorporated
0.00%129.231.9%$271.19m
INCYIncyte Corporation
0.00%130.312.6%$256.98m
CLVSClovis Oncology, Inc.
0.00%89.9618.0%$244.46m
TSROTESARO, Inc.
0.00%141.0314.7%$243.48m
BLUEBluebird Bio, Inc.
0.37%107.3019.3%$160.58m
ILMNIllumina, Inc.
0.00%176.363.5%$150.43m
KITEKite Pharma, Inc.
0.00%98.0516.1%$139.68m
EXASExact Sciences Corporation
0.00%34.0926.3%$128.59m
AAgilent Technologies, Inc.
0.00%58.871.5%$122.37m

Company Profile

Achillion Pharmaceuticals, Inc. engages in the research and development of small molecule drug therapies for infectious diseases and immune system disorders. It intends to commercialize its anti-viral medicines for the treatment of hepatitis C and resistant bacterial infections. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.,0066QK-E